We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
JCVI makes interim recommendations to government on the COVID-19 vaccination programme for 2023.
The Joint Committee on Vaccination and Immunisation (JCVI) has issued its advice on the AstraZeneca COVID-19 vaccine.
The Joint Committee on Vaccination and Immunisation (JCVI) has updated its advice on the COVID-19 vaccine booster programme.
The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice to the government on the use of COVID-19 vaccines to mitigate the impact of the B1.617.2 variant of concern.
JCVI has advised the government to invite all people on the GP Learning Disability Register for COVID-19 vaccination.
The JCVI has issued new advice regarding the AstraZeneca COVID-19 vaccine after reports of extremely rare blood clots.
The Joint Committee on Vaccination and Immunisation (JCVI) has advised an additional spring booster dose for the most vulnerable individuals in the population.
The JCVI is advising that people with severely weakened immune systems should have a third vaccine dose as part of their primary COVID-19 vaccination schedule.
The JCVI has advised the government to prioritise people experiencing homelessness, including those sleeping rough, for the coronavirus (COVID-19) vaccine.
The Joint Committee on Vaccination and Immunisation (JCVI) is today advising that children at increased risk of serious coronavirus (COVID-19) disease are offered a vaccine.
Statement from the Joint Committee on Vaccination and Immunisation (JCVI) on immunisation prioritisation.…
The Joint Committee on Vaccination and Immunisation (JCVI) has updated its vaccination advice for children aged 5 to 11, with a view to increasing protection against potential future waves of coronavirus (COVID-19).
The Joint Committee on Vaccination and Immunisation's (JCVI) final recommendations on changes to the childhood immunisation schedule.
The JCVI has advised that pregnant women should be offered the COVID-19 vaccine at the same time as the rest of the population, based on their age and clinical risk group.
The Joint Committee on Vaccination and Immunisation (JCVI) has considered the evidence for Phase 2 of the UK’s COVID-19 vaccination programme.
JCVI position statement on the use of meningococcal B (MenB) vaccine in the UK.
The Joint Committee on Vaccination and Immunisation (JCVI) has issued advice to the UK government on the use of the coronavirus (COVID-19) Oxford/AstraZeneca vaccine for people aged under 40.
The Joint Committee on Vaccination and Immunisation (JCVI) has provided interim advice to government regarding coronavirus (COVID-19) booster doses this autumn.
The Joint Committee on Vaccination and Immunisation (JCVI) has been asked to consider the options for a potential coronavirus (COVID-19) booster programme.
The JCVI has reviewed the evidence on vaccinating children aged 12 to 15 who do not have underlying health conditions that put them at increased risk from severe COVID-19.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).